|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| (11) | Number of the document | 2978859 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14714628.6 |
| Date of filing the European patent application | 2014-03-24 | |
| (97) | Date of publication of the European application | 2016-02-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation | 2018-09-10 |
| (86) | Number | PCT/EP2014/055790 |
| Date | 2014-03-24 |
| (87) | Number | WO 2014/154606 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 13161386 | 2013-03-27 | EP |
| (72) |
DUBÉ, Marie-Pierre, CA
NIESOR, Eric J., CH
TARDIF, Jean-Claude, CA
UPMANYU, Ruchi, GB
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Genetiniai žymenys atsakomajai reakcijai į gydymą prognozuoti |
| GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 13 | 289.00 EUR |
| 2027-03-24 |